Long
Mid term swing opportunity in CTI BioPharma (CTIC)
Stock had decent drop right after earnings to the lowest channel support line.
Stock is heavily short : 20% of float is short
80% Institutional investors.
nice swing opportunity for a re-bounce to the upper "resistance" channel line.
$NASDAQ:CTIC
Stock is heavily short : 20% of float is short
80% Institutional investors.
nice swing opportunity for a re-bounce to the upper "resistance" channel line.
$NASDAQ:CTIC
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.